FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/058472 [Registered on: 10/10/2023] Trial Registered Prospectively
Last Modified On: 05/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Dexmedetomidine and Dexamethasone, Which is a better adjuvant with Ropivacaine in Adductor canal block? 
Scientific Title of Study   Comparison of Dexmedetomidine and Dexamethasone as adjuvant to Ropivacaine in Ultrasound guided Adductor canal block , for postoperative analgesia in knee Arthroscopic surgeries. A Randomised double blind study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Muhsina K 
Designation  DNB Resident 
Affiliation  BLK Super Speciality Hospital 
Address  Department of Aneasthesiology BLK Super Speciality Hospital Pusa Road, New Delhi, 110005

New Delhi
DELHI
110005
India 
Phone  9539888198  
Fax    
Email  muhsinaasees@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chetan Saraya 
Designation  senior consultant 
Affiliation  BLK Super Speciality Hospital 
Address  Department of Anaesthesiology, BLK Super Speciality Hospital, Pusa Road, New Delhi. 110005
Department of Anaesthesiology, BLK Super Speciality Hospital, Pusa Road, New Delhi. 110005
New Delhi
DELHI
110005
India 
Phone  9539888198  
Fax    
Email  chetansaraya@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Muhsina K 
Designation  DNB Resident 
Affiliation  BLK Super Speciality Hospital 
Address  Department of Anaesthesiology, BLK Super Speciality Hospital, Pusa Road, New Delhi, 110005

New Delhi
DELHI
110005
India 
Phone  9539888198  
Fax    
Email  muhsinaasees@gmail.com  
 
Source of Monetary or Material Support  
BLK Super Speciality Hospital, Pusa Road, New Delhi, 110005 
 
Primary Sponsor  
Name  BLK Super Speciality Hospital 
Address  BLK Super Speciality Hospital, Pusa Road, New Delhi, 110005 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Muhsina K  BLK Super Speciality Hospital  Department of Anaesthesiology, Pusa Road, New Delhi, 110005
New Delhi
DELHI 
9539888198

muhsinaasees@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BLK SUPER SPECIALITY HOSPITAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: M239||Unspecified internal derangement of knee,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Adductor canal block  Ultrasound guided single shot adductor canal block with 20 ml of 0.375% Ropivacaine and adjuvants 
Comparator Agent  Dexmedetomidine and Dexamethasone.  Dexmedetomidine (1 microgram/kilogram body weight) singleshot injection in adductor canal as adjuvant to 20 ml Ropivacaine(0.375%) and Dexamethasone (0.1 milligram/ kilogram body weight) single shot injection in adductor canal as adjuvant to 20 ml Ropivacaine(0.375%) 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Elective knee arthroscopic surgeries under sub arachinoid block, giving consent to postoperative adductor canal block.
Age within 18 to 65, belonging to either gender.
American society of anaesthesiologists grade I and II

 
 
ExclusionCriteria 
Details  Allergy to any of the drugs used.
Any contraindication to adductor canal block and Sub Arachinoid Block, like local infection.
History of diseases like diabetic neuropathy or any other neuropathy.
Any liver dysfunction or renal dysfunction.
Body mass index more than 35.
Patients who are on any anticoagulants or sedatives or having any deranged coagulation profile.
Pregnant females.
Patients with partial Sub Arachinoid Block, in need of additional analgesia during surgery.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Comparison of total analgesia duration.  Total requirement of rescue analgesia over a period of 24 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
PATIENT SATISFACTION SCORE
EARLY TOE MOBILITY
HEMODYNAMIC STABILITY
SIDE EFFECTS, IF ANY 
24 HOURS 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   16/10/2023 
Date of Study Completion (India) 30/12/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is being conducted as part of Post Graduation Curriculum, Our aim is to compare  Dexmedetomidine and Dexamethasone as adjuvant to Ropivacaine in Ultrasounded guided  Adductor canal block for knee Arthroscopic surgeries. We are planning to include patients undergoing elective knee Arthroscopic surgeries under Sub Arachinoid block, who are American Society of Anaesthesiologists grade  I and II. We are intenting to finish the study in 18 months. 
Close